<DOC>
	<DOCNO>NCT01284608</DOCNO>
	<brief_summary>This observational , prospective , non-interventional multi-centre study , assess impact androgen ablation therapy blood triglyceride , cholesterol glucose , body fat distribution fracture risk ten year use FRAX model patient prostate cancer . The patient follow 12 month</brief_summary>
	<brief_title>Metabolic Changes Prostate Cancer Patients With Androgen-ablation Therapy ( AAT )</brief_title>
	<detailed_description />
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Androgens</mesh_term>
	<criteria>Prostate cancer patient require androgenablation treatment : LHRH analog , surgical castration , antiandrogen treatment Provision inform consent prior conduct studyrelated procedure Patient involve Clinical Trial</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2012</verification_date>
	<keyword>Observational</keyword>
	<keyword>prospective</keyword>
	<keyword>metabolic change</keyword>
	<keyword>metabolic syndrome</keyword>
	<keyword>diabetes</keyword>
	<keyword>prostatic cancer</keyword>
	<keyword>risk fracture</keyword>
</DOC>